Becton, Dickinson and Co.’s (BD) diagnostic tool that can check for COVID-19, the flu or respiratory syncytial virus (RSV) has been available in certain European countries since last year. Now, it’s ...
After receiving one of a dwindling number of COVID-era FDA emergency authorizations earlier this year, BD has converted its combination respiratory virus test to a full regulatory green light. The ...
New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global ...
Amid the standard roll call of earnings sheets released in recent weeks, nearly every diagnostics developer marked present has reported a severe drop-off in COVID-19 test sales for the fourth quarter ...
We are maintaining our $306 fair value estimate for narrow-moat Becton, Dickinson as we update our model following fiscal third-quarter results and updated full-year guidance. BD increased its revenue ...
Zacks Investment Research on MSN
BD expands BD MAX with IVDR-approved VIASURE tests in Europe
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually ...
FRANKLIN LAKES, N.J., Feb. 8, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received Emergency Use ...
FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback